Abstract
Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Attitude of Health Personnel
-
Biological Products* / economics
-
Biological Products* / therapeutic use
-
Cost-Benefit Analysis
-
Drug Prescriptions* / economics
-
Drugs, Generic* / economics
-
Drugs, Generic* / therapeutic use
-
Health Care Costs*
-
Humans
-
Physicians*
-
Practice Patterns, Physicians'*
-
Salaries and Fringe Benefits*
-
Surveys and Questionnaires
-
United States
Substances
-
Biological Products
-
Drugs, Generic
Grant support
ASK’s work is supported by an Ignition Award from the Harvard Program in Therapeutic Science. ASK is a Greenwall Faculty Scholar in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.